Literature DB >> 32015437

RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering.

Aaron A Smargon1, Yilan J Shi1,2, Gene W Yeo3,4.   

Abstract

Deployment of RNA-guided DNA endonuclease CRISPR-Cas technology has led to radical advances in biology. As the functional diversity of CRISPR-Cas and parallel systems is further explored, RNA manipulation is emerging as a powerful mode of CRISPR-based engineering. In this Perspective, we chart progress in the RNA-targeting CRISPR-Cas (RCas) field and illustrate how continuing evolution in scientific discovery translates into applications for RNA biology and insights into mysteries, obstacles, and alternative technologies that lie ahead.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32015437      PMCID: PMC8008746          DOI: 10.1038/s41556-019-0454-7

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  101 in total

Review 1.  CRISPR-Cas immunity in prokaryotes.

Authors:  Luciano A Marraffini
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

2.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

Review 3.  Classification and Nomenclature of CRISPR-Cas Systems: Where from Here?

Authors:  Kira S Makarova; Yuri I Wolf; Eugene V Koonin
Journal:  CRISPR J       Date:  2018-10

Review 4.  Development and applications of CRISPR-Cas9 for genome engineering.

Authors:  Patrick D Hsu; Eric S Lander; Feng Zhang
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

Review 6.  Diversity, classification and evolution of CRISPR-Cas systems.

Authors:  Eugene V Koonin; Kira S Makarova; Feng Zhang
Journal:  Curr Opin Microbiol       Date:  2017-06-09       Impact factor: 7.934

7.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

8.  Localization of ASH1 mRNA particles in living yeast.

Authors:  E Bertrand; P Chartrand; M Schaefer; S M Shenoy; R H Singer; R M Long
Journal:  Mol Cell       Date:  1998-10       Impact factor: 17.970

9.  mRNA stabilization by poly(A) binding protein is independent of poly(A) and requires translation.

Authors:  J M Coller; N K Gray; M P Wickens
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

10.  Programmable RNA recognition and cleavage by CRISPR/Cas9.

Authors:  Mitchell R O'Connell; Benjamin L Oakes; Samuel H Sternberg; Alexandra East-Seletsky; Matias Kaplan; Jennifer A Doudna
Journal:  Nature       Date:  2014-09-28       Impact factor: 49.962

View more
  16 in total

Review 1.  Engineering Closed-Loop, Autoregulatory Gene Circuits for Osteoarthritis Cell-Based Therapies.

Authors:  Rhima M Coleman
Journal:  Curr Rheumatol Rep       Date:  2022-04-11       Impact factor: 4.592

2.  Double-edged role of resource competition in gene expression noise and control.

Authors:  Hanah Goetz; Austin Stone; Rong Zhang; Ying-Cheng Lai; Xiao-Jun Tian
Journal:  Adv Genet (Hoboken)       Date:  2022-02-08

3.  Type III-A CRISPR systems as a versatile gene knockdown technology.

Authors:  Walter T Woodside; Nikita Vantsev; Ryan J Catchpole; Sandra C Garrett; Sara Olson; Brenton R Graveley; Michael P Terns
Journal:  RNA       Date:  2022-05-26       Impact factor: 5.636

4.  Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice.

Authors:  Yang Guo; Lei Han; Shuang Han; Honghai Tang; Shengyi Wang; Chong Cui; Bing Chen; Huawei Li; Yilai Shu
Journal:  Mol Ther Nucleic Acids       Date:  2022-04-26       Impact factor: 10.183

5.  Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes.

Authors:  Chunlong Xu; Yingsi Zhou; Qingquan Xiao; Bingbing He; Guannan Geng; Zikang Wang; Birong Cao; Xue Dong; Weiya Bai; Yifan Wang; Xiang Wang; Dongming Zhou; Tanglong Yuan; Xiaona Huo; Jinsheng Lai; Hui Yang
Journal:  Nat Methods       Date:  2021-05-03       Impact factor: 28.547

Review 6.  Using CRISPR to understand and manipulate gene regulation.

Authors:  Ersin Akinci; Marisa C Hamilton; Benyapa Khowpinitchai; Richard I Sherwood
Journal:  Development       Date:  2021-04-29       Impact factor: 6.868

Review 7.  Emerging strategies for the genetic dissection of gene functions, cell types, and neural circuits in the mammalian brain.

Authors:  Ling Gong; Xue Liu; Jinyun Wu; Miao He
Journal:  Mol Psychiatry       Date:  2021-09-24       Impact factor: 15.992

8.  Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells.

Authors:  Alejandro Méndez-Mancilla; Hans-Hermann Wessels; Mateusz Legut; Anastasia Kadina; Megumu Mabuchi; John Walker; G Brett Robb; Kevin Holden; Neville E Sanjana
Journal:  Cell Chem Biol       Date:  2021-08-02       Impact factor: 8.116

Review 9.  Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.

Authors:  Vanja Perčulija; Jinying Lin; Bo Zhang; Songying Ouyang
Journal:  Adv Sci (Weinh)       Date:  2021-05-05       Impact factor: 16.806

10.  Cancer biology functional genomics: From small RNAs to big dreams.

Authors:  Soumya Sundara Rajan; Katelyn R Ludwig; Katherine L Hall; Tamara L Jones; Natasha J Caplen
Journal:  Mol Carcinog       Date:  2020-10-12       Impact factor: 5.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.